News & Blog

Tag Archives: NIH

Guest Blog: How My Brain Finds New Solutions

Life can change so quickly. I was only 24 years old in 1998 working in the U.S. Congress with plans for law school. But, the unexpected emerged when I was diagnosed with a brain tumor. Shocked and shattered, I entered a new world. Necessity can become a powerful teacher. I conducted research that helped me […]

So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development

Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […]

From the CEO’s Desk: Busy Season for Public Policy Kicks Into Gear

The first quarter of the year for the National Brain Tumor Society (NBTS) – and any other organization engaged in proactive advocacy – is a particularly busy time in the area of public policy and government relations. While research initiatives often spillover year-to-year and remain ongoing (like our flagship research initiative, the Defeat GBM Research Collaborative, which is a […]

Share